BAP1 and neoplasm: They include tumor size, chromosome 3 monosomy, loss of BRCA1 associated protein-1 (BAP1), eukaryotic translation initiation factor 1 (EIFAX) and splicing factor 3 subunit 1 (SF3B1) mutations (increasing the risk of metastases in disomy 3 tumors) (Kaliki and Shields, 2017; Robertson et al., 2017).